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The potential association between sickle cell trait (SCT) and increased arterial stiffness/blood pressure (BP) has
not been evaluated in detail despite its association with stroke, sudden death, and renal disease. We performed
24-hour ambulatory BP monitoring and arterial stiffness measurements in adolescents raised in a malaria-free
environment in Kenya. Between December 2015 and June 2016, 938 randomly selected adolescents (ages 11–17
years) who had been continuous residents of Nairobi from birth were invited to participate in the study. Standard
clinic BP measurement was performed, followed by 24-hour ambulatory BP monitoring and arterial stiffness mea-
surement using an Arteriograph24 (TensioMed Ltd., Budapest, Hungary) device. SCT status was determined
using DNA genotyping in contemporaneously collected blood samples. Of the 938 adolescents invited to partici-
pate, 609 (65%) provided complete data for analysis. SCT was present in 103 (15%). Mean 24-hour systolic and
diastolic BPs were 116 (standard deviation (SD), 11.5) mmHg and 64 (SD, 7) mmHg, respectively, in children with
SCT and 117 (SD, 11.4) mm Hg and 64 (SD, 6.8) mm Hg, respectively, in non-SCT children. Mean pulse wave
velocity (PWV) was 7.1 (SD, 0.8) m/second and 7.0 (SD, 0.8) m/second in SCT and non-SCT children, respec-
tively. We observed no differences in PWV or in any clinic or ambulatory BP-derived measures between adoles-
cents with and without SCT. These data suggest that SCT does not independently inﬂuence BP or PWV.
arterial stiffness; blood pressure; hypertension; sickle cell trait
Abbreviations: ABPM, ambulatory blood pressure monitoring; BP, blood pressure; CI, conﬁdence interval; eGFR, estimated
glomerular ﬁltration rate; PWV, pulse wave velocity; SCT, sickle cell trait; SD, standard deviation.
The sickle cell trait (SCT), common among populations of
African descent (1) due to the protection it offers against
malaria (2–4), has been associated with increased risk of car-
diovascular and renal disease (5–8). However, the underlying
mechanisms of this increased risk have not been elucidated
clearly, hampering measures that can be implemented to
reduce risk in carriers.
Persons of African descent have relatively higher blood
pressures (BPs) than other ethnic groups (9), and it is conceiv-
able that increased BP and/or arterial stiffness, which have
been shown to precede clinical events similar to those seen in
persons with SCT, could precede the events observed in SCT
carriers (8, 10, 11). Alternatively, increased arterial stiffness
and BP in persons with SCT could result from the yet-to-be-
elucidated mechanisms that lead to cardiovascular and renal
events.
Previous studies that assessed BP and/or arterial stiffness in
persons with SCT had several weaknesses. Rossi-Espagnet
et al. (12), in a study conducted in Colombia in 1968, found
no difference in BP between persons with and without SCT.
However, BP measurements were performed only once at
home visits; there was a poor response rate in men; and the
data were susceptible to confounding by malaria, which SCT
protects against (2–4) and which is possibly related to BP (13, 14).
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Bayramoğlu et al. (15) found similar arterial stiffness indices in
young Turkish adults with and without SCT, but the sample size
was small. Although the studies demonstrating increased car-
diovascular and renal disease risk in SCT assessed BP at base-
line, the BP measurements were taken in the clinic/ofﬁce, using
manual or automatedmethods (7, 8). None of these studies uti-
lized 24-hour ambulatory blood pressure monitoring (ABPM),
which is considered the reference method for BP measurement
(16, 17), raising the possibility that subtle but signiﬁcant dif-
ferences in BP could have beenmissed (17). ABPM overcomes
many of the limitations of ofﬁce/clinic BP measurement (17).
ABPM also enables detection of masked hypertension (normal
clinic BP but elevated 24-hour BP), a cardiovascular risk
factor (18) that is more common in populations of African
descent (19)—the same population that has a high prevalence
of SCT.
If arterial stiffness and/or BP are increased in young persons
with SCT, they could become the target of interventions aimed
at reducing future cardiovascular and renal events. We con-
ducted a population-based study in Nairobi, Kenya, to deter-
mine whether SCT inﬂuences arterial stiffness and BP among
adolescents who have hadminimal exposure to malaria.
METHODS
The study was conducted from December 2015 to June
2016 in a cross-sectional sample of residents of the area cov-
ered by the Nairobi Urban Health and Demographic Surveil-
lance System (20). The area has a population of approximately
70,000, and the prevalence of hypertension is high (21). Nairobi,
the capital city of Kenya, was chosen for this study for 2 reasons.
First, Nairobi is located at a high altitude (1,800 m above sea
level), and there is no evidence of malaria transmission there
(22). This made it possible to study the association of SCT
with BP unconfounded by the presence of malaria. This was
necessary because malaria could inﬂuence BP (14), and at the
same time SCT protects against malaria (3, 4). Second, the
population of Nairobi is composed of ethnic groups originating
in all parts of the country, including those whose ancestral lands
were endemic for malaria (e.g., Luhya, Luo, Teso, Mijikenda).
The frequency of the sickle cell gene ismuch higher among these
ethnic groups (23). In order to increase our efﬁciency in re-
cruiting participants with SCT, we limited our recruitment to
those who identiﬁed themselves as genetically descended from
one of these ethnic groups.
Population-wide censuses are conducted 4 times a year
within the study area (20). Using census data, we selected all
children currently aged 11–17 years who had a continuous
record of residence in the area since birth. Continuous resi-
dency was a requirement so as to minimize potential exposure
to malaria as a result of migration. Trained staff visited all sub-
jects who had been selected to participate in the study at their
homes. Parents of the children were then asked to bring them
to the nearer of 2 study clinics within the area to undergo study
procedures. Subjects who failed to come to the clinic within 3
months of being requested to do so were considered to have
refused to participate in the study.
Subjects and/or their parents ﬁrst underwent an interview in
which they answered questions about their medical history
and their socioeconomic status, based on themultidimensional
poverty index (24). Weight and height were measured using a
validated Seca 874 ﬂat scale and a portable stadiometer (Seca
213) (Seca GmbH & Co. KG, Hamburg, Germany), respec-
tively. Mid-upper arm circumference was measured in a stan-
dardized manner using Teaching-aids at Low Cost (TALC)
tapes (Health Books International, Hertfordshire, United
Kingdom).We then took a screening BPmeasurement using a
validated automated Omron M10-IT BP monitor (Omron
Healthcare Europe B.V., Hoofddorp, the Netherlands). An
appropriate-size cuff was placed on the nondominant arm after
the subject had been seated for at least 5 minutes. Three BP
measurements were taken over a 5-minute period, and the
mean of the last 2 measurements was recorded as the screen-
ing BP value. All participants were subsequently ﬁtted with an
Arteriograph24 device (TensioMed Ltd., Budapest, Hungary)
for 24-hour ABPM and determination of pulse wave velocity
(PWV) (25). The devices, which have been calibrated in chil-
dren (26), were programmed to take measurements every 20
minutes during daytime hours (06:00–22:00 hours (6 AM–10
PM)) and every 40 minutes at night (22:00–06:00 hours (10
PM–6 AM)).
Laboratory procedures
We collected 10 mL of blood from participants for a full
blood count, determination of sickle hemoglobin status, and
measurement of serum electrolytes. After automated full
blood counts were performed using an AcT 5 diff AL Hema-
tology Analyzer (Beckman Coulter, Inc., Brea, California),
whole blood samples were frozen at -80°C and then trans-
ported to the KEMRIWellcome Trust Research Programme
laboratories in Kiliﬁ, Kenya, for determination of sickle hemo-
globin status. DNAwas extracted retrospectively from the frozen
samples by use of QIAamp DNA Blood Mini Kits (QIAGEN
Ltd., Crawley, United Kingdom) and typed for sickle hemoglo-
bin using polymerase chain reaction.
Serum and urine samples collected from participants were
frozen at −80°C within 4 hours of collection and later trans-
ported to Kiliﬁ for analysis. We determined levels of sodium,
potassium, urea, and creatinine in these samples using ion
electrophoresis and the Jaffe method, respectively (27). We
additionally determined albumin levels in the urine samples
by immunoturbidometry using a Quantex microalbumin kit
(Instrumentation Laboratory, Barcelona, Spain).
Statistical methods
Based on an expected minimum prevalence of 10% SCT in
the ethnic groups we were studying, a systolic BP standard
deviation of 15 mmHg, and 30% attrition due to poor-quality
ABPM data, we estimated that a total of 550 participants
would provide 80% power to detect a 0.5-standard-deviation
(7.5-mm Hg) difference in 24-hour systolic BP between chil-
dren with and without SCT.
Because there are no published criteria for acceptable
ABPM data in children, we used guidelines for completeness
of ABPM data in adults from the International Database of
Ambulatory Blood Pressure in Relation to Cardiovascular
Outcome (IDACO) Study (28). Speciﬁcally, ABPM data
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were considered to be of acceptable quality if they met the fol-
lowing criteria: minimum of 10 daytime readings and mini-
mum of 5 nighttime readings, where day was deﬁned as
10:00–20:00 hours (10 AM–8 PM) and night as 00:00–06:00
hours (12 AM–6 AM) (28). The same time periods were used to
determine average daytime and nighttime BPs and to evaluate
dipping status. Time weighting was applied in calculating
average BP values for all time periods (29).
We deﬁned children screening positive for hypertension as
those for whom the mean of the last 2 clinic BPmeasurements
was above the 95th percentile for their age, sex, and height
(16). Children with conﬁrmed hypertension were those whose
24-hour average systolic and/or diastolic BPs were above the
95th percentile for their sex, age, and height (16).
Using the combination of clinic BP measurements and
ABPM, we categorized all subjects who were not on antihyper-
tensive medication into 4 categories: sustained hypertensives
(screen-positive and conﬁrmed hypertensive on ABPM); white-
coat hypertensives (screen-positive, not conﬁrmed hypertensive
on ABPM); masked hypertensives (screen-negative, conﬁrmed
hypertensive on ABPM); and normotensives (screen-negative,
not conﬁrmed hypertensive on ABPM) (30).
Nocturnal blood pressure dipping was deﬁned using
ABPM data only, using day and night periods as deﬁned
above. Subjects were classiﬁed using the following 4 catego-
ries, based on the night/day ratio of mean systolic and/or dia-
stolic BPs: rising or absence of dipping (ratio ≥1.0); mild
dipping (0.9 < ratio ≤ 1.0); dipping (0.8 < ratio ≤ 0.9); and
extreme dipping (ratio≤0.8) (31).
Estimated glomerular ﬁltration rate (eGFR) was calculated
using the Schwartz formula (32).
Summary statistics computed included mean values,
median values, and proportions as appropriate. Comparisons
between SCT carriers and noncarriers were made using Stu-
dent’s t test and χ2 tests as appropriate. Data that were not nor-
mally distributed were log-transformed prior to analysis. We
compared ABPM and arterial stiffness measures between chil-
dren with and without the SCT by Student’s t test. In addition,
we performed a multivariate regression analysis testing the
association of SCT carrier status with mean 24-hour systolic
and diastolic BP, with sex, age, body mass index, PWV, and
eGFR included as covariates.
All analyses were conducted using Stata software, version
12 (StataCorp LP, College Station, Texas).
The Ethical Review Committee of the Kenya Medical
Research Institute (KEMRI) approved the study. Written
informed consent was obtained from the parents of study par-
ticipants. Participating children also provided written assent.
RESULTS
Of the 938 subjects asked to participate in the study, 686
(73%) completed enrollment (Figure 1). The 252 adolescents
who were not recruited into the study were 0.6 years (95%
conﬁdence interval (CI): 0.3, 0.9) older than study participants
but had a similar sex distribution (53% female) as those who
participated in the study. Genotype data were available for 644
subjects, 609 (95%) of whom had complete ABPM data. SCT
was present in 103 participants (15%). The proportion of
participants with complete ABPM data did not differ by SCT
status (91% vs. 90%; P = 0.817) or any of the other demo-
graphic and clinical data collected. One participant had sickle
cell disease (hemoglobin SS) and was dropped from analyses.
None of the participants were previously aware of their SCT
carrier status.
Mean systolic and diastolic clinic BPs among all partici-
pants were 98 (standard deviation (SD), 11) mm Hg and 64
(SD, 8) mm Hg, respectively. The mean 24-hour systolic and
diastolic BPs for all participants were 117 (SD, 11) mm Hg
and 64 (SD, 7) mmHg, respectively. Mean 24-hour PWVwas
7 (SD, 0.8) m/second. Based on the data accrued, the study
had greater than 98% power to detect a 5-mmHg difference in
systolic BP (0.4 SDs), a 4-mm Hg difference in diastolic BP
(0.5 SDs), and a 0.4-m/second difference in PWV (0.5 SDs)
between children with SCT and those without SCT.
Table 1 displays the characteristics of the participants ac-
cording to SCT carrier status. The mean 24-hour systolic
and diastolic BPs in subjects with SCT were 116 (SD, 11.5)
mm Hg and 64 (SD, 7) mm Hg, respectively. In subjects
without SCT, the corresponding 24-hour BP values were
117 (SD, 11.4) mm Hg and 64 (SD, 6.8) mm Hg, respec-
tively (P = 0.8551 and P = 0.9691, respectively, for com-
parison between SCT carriers and noncarriers). There were
no statistically signiﬁcant between-group differences in
eGFR, clinic BP, clinic PWV, or 24-hour PWV. There were
no between-group differences in the prevalence of masked
hypertension, white-coat hypertension, or nondipping status.
Urinary sodium and potassium concentrations were 19.5 mmol/L
No. of Residents Requested
to Participate in Study
(n = 938)
Subjects With Complete Data Available
(n = 609)
Failed to Come to Clinic
(n = 176)
Came to Clinic
(n = 762)
Refused Consent
(n = 76)
Poor-Quality ABPM Data (n = 35)
Missing Blood/Urine Sample (n = 42)
Figure 1. Selection of adolescent participants (ages 11–17 years)
for a study of the association between sickle cell trait and blood pres-
sure, Nairobi, Kenya, 2015–2016. ABPM, ambulatory blood pressure
monitoring.
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(95% CI: 1.4, 37.6; P = 0.0352) and 13.5 mmol/L (CI: 5.8, 21.2;
P = 0. 0006) lower in SCT carriers than in noncarriers.
Figure 2 displays the distributions of 24-hour, daytime, and
nighttime BPs in study participants by SCT carrier status. All
measures were similar for SCT carriers and noncarriers.
Table 2 displays the results of regression analyses examin-
ing whether SCT inﬂuenced 24-hour systolic and diastolic BP
after adjustment for age, sex, body mass index, eGFR, and
PWV. While age, sex, body mass index, and eGFR were all
associated with 24-hour systolic BP, there was no association
between SCT and 24-hour BP measures. PWV displayed the
strongest association with both systolic and diastolic BP. Addi-
tional adjustment for urinary sodium and potassium levels made
nomaterial difference in the results.
DISCUSSION
It has previously been hypothesized that the excess risk of
cardiovascular disease observed in African populations may
result from pleiotropic effects of genetic polymorphisms that
protect them from common infections during childhood. An
elegant example of this is variants of the apolipoprotein L1
gene (APOL1), which, while reducing the risk of trypanoso-
miasis, increase the risk of hypertension-associated chronic
kidney disease (33). Malaria has exerted the strongest known
selective pressure on the human genome, SCT being promi-
nent among the polymorphisms under positive selection (34).
Given the previously documented excess cardiovascular and
renal events observed in both sickle cell disease and SCT, we
hypothesized that persons with SCT would have different BPs
than those without SCT.
In this detailed study of BP phenotypes and arterial stiffness
among adolescents who were selected because they had had
little exposure to malaria throughout childhood, we did not
ﬁnd any differences between those with and without SCT.
Because the exposure measurement was a genetic trait
acquired at conception and the participants were ascertained
to have remained in the same malaria-free environment since
Table 1. Characteristics of Adolescent Study Subjects (Ages 11–17 Years) According to Sickle Cell Trait Carrier
Status, Nairobi, Kenya, 2015–2016
Characteristic
SCTNoncarriers (n = 567) SCT Carriers (n = 103)
P ValueNo. of
Children % Mean (SD)
No. of
Children % Mean (SD)
Female sex 323 57 49 48 0.08
Complete ABPMdata 516 91 93 90 0.82
White-coat hypertensiona 23 44 3 3 0.59
Masked hypertensiona 37 7 8 9 0.63
Nondipping BP patterna 17 3 2 2 0.55
Age, years 13.2 (2.2) 13.8 (2.3) 0.09
Bodymass indexb 18.8 (3.1) 19.0 (3.1) 0.63
Mid-upper arm circumference, cm 23.2 (3.6) 23.5 (3.8) 0.41
Hemoglobin concentration, mg/dL 13.2 (1.5) 13.4 (1.6) 0.15
White blood cell count, cells × 109/L 5.5 (1.5) 5.6 (1.3) 0.78
Platelet count, cells × 109/L 310.4 (86.5) 305.8 (95.3) 0.64
Serum sodium level, mmol/L 139.1 (6.3) 139.1 (5.6) 0.94
Serum potassium level, mmol/L 4.9 (0.6) 5.0 (0.8) 0.09
Socioeconomic status (MDPI scorec) 2.2 (1.3) 2.1 (1.3) 0.55
Clinic BP, mmHg
Systolic 98.2 (10.8) 99.3 (12.6) 0.31
Diastolic 63.6 (8.1) 64.4 (8.9) 0.32
Pulse wave velocity, m/second 7.0 (0.8) 7.1 (0.8) 0.26
eGFR, mL/minute/1.73 m2 110.3 (14.0) 107.8 (14.2) 0.12
Urinary albumin:creatinine ratio 3.6 (17.5) 3.5 (7.5) 0.96
Urinary sodium level, mmol/L 135.7 (73.1) 119.1 (45.4) 0.03
Urinary potassium level, mmol/L 48.4 (30.5) 36.2 (23.2) 0.0001
Abbreviations: ABPM, ambulatory blood pressure monitoring; BP, blood pressure; eGFR, estimated glomerular ﬁl-
tration rate; MDPI, multidimensional poverty index; SCT, sickle cell trait; SD, standard deviation.
a Data on white-coat hypertension, masked hypertension, and nondipping pattern were based on the 609 children
with complete ABPMdata.
b Weight (kg)/height (m)2.
c A household is considered poor if the MDPI score is greater than 3.
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birth, we believe that this study suggests that a direct effect of
SCT on BP and indices of arterial stiffness is highly improba-
ble within the ﬁrst 11–17 years of life.
Urinary albumin:creatinine ratio and eGFR were the same
in SCT carriers and noncarriers in this study. In a study con-
ducted among blacks in the United States showing increased
renal events in SCT carriers, most participants were recruited
at 45 years of age and above (8), much older than the popula-
tion we recruited in this study. However, we found signiﬁ-
cantly lower urinary electrolyte levels in SCT carriers, which
could be attributed to the hyposthenuria (impaired urine-
concentrating ability) that has previously been described in
SCT (35).
While we failed to detect any meaningful effect of SCT on
BP and arterial stiffness, the results of this study do have
important implications. It seems unlikely that increased BP
and arterial stiffness precede or are involved in the pathogene-
sis of cardiovascular and renal events in persons with SCT. In
view of this, studies of other biomarkers that could predict the
development of chronic kidney disease in persons with SCT
are warranted. Because persons with SCT form a signiﬁcant
proportion of the population in many developing countries, as
well as in developed countries, early identiﬁcation of risk fac-
tors in this subgroup of individuals could have signiﬁcant
population-wide beneﬁts.
An alternative to the hypothesis that genetic variations pro-
tective against infectious diseases predispose people to car-
diovascular disease is that in some instances the infectious
diseases themselves may have long-term consequences in sur-
vivors, including the development of hypertension (14). One
robust way to test such hypotheses is by utilizing Mendelian
randomization techniques in which BP is compared in persons
with and without genetic variants that are associated with the
infectious disease. An important prerequisite for using these
variants is that they should not affect the outcome (BP) in the
absence of the infectious disease (malaria). The results of this
study suggest that SCT does not inﬂuence BP in the absence
of malaria and can therefore be used as an instrumental variable
in Mendelian randomization studies to test the malaria–high
BP hypothesis (14). SCT is a particularly attractive candidate for
such studies, as it is relatively common in areas with malaria and
displays a very strong protective effect against both mild and
severe malaria (2, 4), thus reducing sample size requirements for
such studies. Conﬁrmation of the hypothesis would represent
a paradigm shift in understanding the pathogenesis of hyper-
tension in many developing-country settings where malaria is
endemic (36).
A major strength of this population-based study was the use
of ABPM, which is considered the reference standard for BP
measurement in children (16). The study had enough power to
detect very small differences in BP and PWV. We also used
health and demographic surveillance system records that were
prospectively collected in order to ascertain residence in a
nonmalaria zone, there being no better method of doing this
in sub-Saharan Africa.
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Figure 2. Ambulatory blood pressure monitoring measurements
among adolescents aged 11–17 years according to sickle cell trait (SCT)
carrier status, Nairobi, Kenya, 2015–2016. For each set of 24-hour, day-
time (08:00–20:00 hours (8 AM–8 PM)), and nighttime (00:00–06:00 hours
(12 AM–6 AM)) measures, the plots on the left are for systolic blood pres-
sure and those on the right are for diastolic blood pressure. Bars, 95%
conﬁdence intervals.
Table 2. Predictors of Mean 24-Hour Systolic and Diastolic Blood Pressures Among Adolescents Aged 11–17
Years, Nairobi, Kenya, 2015–2016a
Characteristic
24-Hour SBP 24-Hour DBP
β 95%CI P Value β 95%CI P Value
Age, years 0.60 0.10, 1.10 0.03 0.01 –0.30, 0.30 0.96
Male sex 2.40 0.40, 4.30 0.02 –0.06 –1.30, 1.20 0.92
Bodymass indexb 0.60 0.20, 1.00 0.001 0.20 –0.09, 0.40 0.21
eGFR, mL/minute/1.73 m2 0.08 0.01, 0.15 0.02 0.01 –0.03, 0.05 0.58
Pulse wave velocity, m/second 2.80 1.60, 4.10 <0.001 2.70 1.90, 3.50 <0.001
Sickle cell trait carrier status 0.10 –2.40, 2.60 0.92 0.40 –1.10, 2.00 0.58
Abbreviations: CI, conﬁdence interval; DBP, diastolic blood pressure; eGFR, estimated glomerular ﬁltration rate;
SBP, systolic blood pressure.
a Multivariate analyses were conducted using data from participants who had complete ambulatory blood pressure
monitoring data (n = 609).
b Weight (kg)/height (m)2.
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A potential limitation of this study was the limited age
range of subjects recruited, necessitated by the fact that there
were no long-term residency records for older individuals.
Most demographic surveillance systems in Africa were estab-
lished between the late 1990s and the early 2000s (37). Re-
cruiting older persons would have compromised data on
residency status in childhood, the period when malaria risk is
highest. In addition, older subjects would be more likely to
have acquired additional risk factors for hypertension, includ-
ing chronic kidney disease, that would have confounded the
analyses. While BP differences are likely to be larger at older
ages, it is known that differences in adult BP emerge in child-
hood (38, 39) and that childhood BP levels are predictive of
adult BP (40). Therefore, the absence of even a small differ-
ence in carefully measured BP and arterial stiffness in our study
of adolescents suggests that it is very unlikely such differences
would emerge in the future.
Although the study had sufﬁcient power to detect differences
in continuous variables such as mean nighttime and daytime
BP, it lacked power to detect differences in the prevalences of
categorical variables such as masked hypertension and white-
coat hypertension. This could form the basis of future studies.
An additional limitation of this study is the fact that, as with
many BP measurement devices, validation studies for the Ar-
teriograph24 have only been done in adults (25). It is unlikely,
however, that measurement error signiﬁcantly inﬂuenced the
result, as the oscillometric principle used by the device has
been validated in children and is particularly suited for pediat-
ric ambulatory BP studies (16, 41).
Nonresponders in this study were slightly older than those
who participated, but the 0.6-year difference is unlikely to
have signiﬁcantly biased our results. We also observed no sig-
niﬁcant differences between children who had acceptable
ABPM data and those who did not, suggesting that the data
presented are representative of the larger population of per-
sons with SCT.
In summary, we have demonstrated that the presence of
SCT does not inﬂuence BP and arterial stiffness in Kenyan
adolescents.
ACKNOWLEDGMENTS
Author afﬁliations: KEMRIWellcome Trust Research
Programme, Kiliﬁ, Kenya (Anthony O. Etyang, Sailoki
Kapesa, EstherMuthumbi, Emily Odipo, Thomas N.
Williams, JohnstoneMakale, AlexMacharia, J. Anthony. G
Scott); London School of Hygiene and TropicalMedicine,
London, United Kingdom (Anthony O. Etyang, Liam
Smeeth, J. Anthony G. Scott); African Population and Health
Research Center, Nairobi, Kenya (Christopher K.Wandabwa,
MaryleneWamukoya, Nicholas Ngomi, TilahunHaregu,
Catherine Kyobutungi); Imperial College London, London,
United Kingdom (Thomas N.Williams); and King’s College
London, London, United Kingdom (J. Kennedy
Cruickshank).
A.O.E., L.S., T.N.W., and J.A.G.S. were supported by the
Wellcome Trust (fellowships 103951/Z/14/Z, 098532,
091758, and 098504).
We thank the ﬁeld and laboratory staff at the African
Population and Health Research Center and the KEMRI
Wellcome Trust Research Programme for their help. We
thank Professor Michael English for reviewing an earlier
version of the manuscript.
This paper is published with the approval of the Director of
the KenyaMedical Research Institute. The funders played no
role in the preparation of this article. The corresponding
author had full access to all of the data in the study and takes
responsibility for the integrity of the data and the accuracy of
the data analysis.
Conﬂict of interest: none declared.
REFERENCES
1. Piel FB, Tatem AJ, Huang Z, et al. Global migration and the
changing distribution of sickle haemoglobin: a quantitative
study of temporal trends between 1960 and 2000. Lancet Glob
Health. 2014;2(2):e80–e89.
2. Williams TN,Mwangi TW,Wambua S, et al. Sickle cell trait
and the risk of Plasmodium falciparummalaria and other
childhood diseases. J Infect Dis. 2005;192(1):178–186.
3. Hill AV, Allsopp CE, Kwiatkowski D, et al. CommonWest
African HLA antigens are associated with protection from
severe malaria. Nature. 1991;352(6336):595–600.
4. Malaria Genomic Epidemiology Network. Reappraisal of
known malaria resistance loci in a large multicenter study.Nat
Genet. 2014;46(11):1197–1204.
5. Key NS, Derebail VK. Sickle-cell trait: novel clinical
signiﬁcance.Hematology Am Soc Hematol Educ Program.
2010;2010:418–422.
6. Kark JA, Posey DM. Sickle-cell trait as a risk factor for sudden
death in physical training.NEngl JMed. 1987;317(13):781–787.
7. CaugheyMC, Loehr LR, Key NS, et al. Sickle cell trait and
incident ischemic stroke in the Atherosclerosis Risk in
Communities Study. Stroke. 2014;45(10):2863–2867.
8. Naik RP, Derebail VK, GramsME, et al. Association of sickle
cell trait with chronic kidney disease and albuminuria in
African Americans. JAMA. 2014;312(20):2115–2125.
9. Opie LH, Seedat YK. Hypertension in sub-Saharan African
populations. Circulation. 2005;112(23):3562–3568.
10. Hsu CY,McCulloch CE,Darbinian J, et al. Elevated blood
pressure and risk of end-stage renal disease in subjects without
baseline kidney disease. Arch InternMed. 2005;165(8):923–928.
11. Ben-Shlomo Y, Spears M, Boustred C, et al. Aortic pulse wave
velocity improves cardiovascular event prediction: an
individual participant meta-analysis of prospective
observational data from 17,635 subjects. J Am Coll Cardiol.
2014;63(7):636–646.
12. Rossi-Espagnet A, Newell KW,MacLennan R, et al. The
relationship of sickle cell trait to variations in blood pressure.
Am J Epidemiol. 1968;88(1):33–44.
13. Ayoola OO, Omotade OO, Gemmell I, et al. The impact of
malaria in pregnancy on changes in blood pressure in children
during their ﬁrst year of life.Hypertension. 2014;63(1):
167–172.
14. Etyang AO, Smeeth L, Cruickshank JK, et al. The malaria-high
blood pressure hypothesis.Circ Res. 2016;119(1):36–40.
15. Bayramoğlu T, Akkus¸ O, Nas K, et al. Arterial stiffness and
pulse wave reﬂection in young adult heterozygous sickle cell
carriers. Turk J Haematol. 2013;30(4):379–386.
16. Flynn JT, Daniels SR, Hayman LL, et al. Update: ambulatory
blood pressure monitoring in children and adolescents:
Am J Epidemiol. 2018;187(2):199–205
204 Etyang et al.
Downloaded from https://academic.oup.com/aje/article-abstract/187/2/199/3867261
by King's College London user
on 05 March 2018
a scientiﬁc statement from the American Heart Association.
Hypertension. 2014;63(5):1116–1135.
17. O’Brien E, Parati G, Stergiou G, et al. European Society of
Hypertension position paper on ambulatory blood pressure
monitoring. J Hypertens. 2013;31(9):1731–1768.
18. Ohkubo T, KikuyaM,Metoki H, et al. Prognosis of “masked”
hypertension and “white-coat” hypertension detected by 24-h
ambulatory blood pressure monitoring: 10-year follow-up from
the Ohasama Study. J Am Coll Cardiol. 2005;46(3):508–515.
19. Tientcheu D, Ayers C, Das SR, et al. Target organ
complications and cardiovascular events associated with
masked hypertension and white-coat hypertension: analysis
from the Dallas Heart Study. J Am Coll Cardiol. 2015;66(20):
2159–2169.
20. Beguy D, Elung’ata P, Mberu B, et al. Health & demographic
surveillance system proﬁle: the Nairobi Urban Health and
Demographic Surveillance System (NUHDSS). Int J
Epidemiol. 2015;44(2):462–471.
21. van de Vijver SJ, Oti SO, Agyemang C, et al. Prevalence,
awareness, treatment and control of hypertension among slum
dwellers in Nairobi, Kenya. J Hypertens. 2013;31(5):
1018–1024.
22. Mudhune SA, Okiro EA, Noor AM, et al. The clinical burden
of malaria in Nairobi: a historical review and contemporary
audit.Malar J. 2011;10(1):138.
23. Foy H, Kondi A, Timms GL, et al. The variability of sickle cell
rates in the tribes of Kenya and the Southern Sudan. Br Med J.
1954;1(4857):294–297.
24. Alkire S, Foster J. Understandings and misunderstandings of
multidimensional poverty measurement. J Econ Inequal. 2011;
9(2):289–314.
25. Horváth IG, Németh A, Lenkey Z, et al. Invasive validation of
a new oscillometric device (Arteriograph) for measuring
augmentation index, central blood pressure and aortic pulse
wave velocity. J Hypertens. 2010;28(10):2068–2075.
26. Hidvégi EV, Illyés M, Benczúr B, et al. Reference values of
aortic pulse wave velocity in a large healthy population aged
between 3 and 18 years. J Hypertens. 2012;30(12):2314–2321.
27. Narayanan S, Appleton HD. Creatinine: a review.Clin Chem.
1980;26(8):1119–1126.
28. Thijs L, Hansen TW, KikuyaM, et al. The International
Database of Ambulatory Blood Pressure in relation to
Cardiovascular Outcome (IDACO): protocol and research
perspectives. Blood Press Monit. 2007;12(4):255–262.
29. Octavio JA, Contreras J, Amair P, et al. Time-weighted vs.
conventional quantiﬁcation of 24-h average systolic and
diastolic ambulatory blood pressures. J Hypertens. 2010;28(3):
459–464.
30. Pickering TG, Eguchi K, Kario K. Masked hypertension: a
review.Hypertens Res. 2007;30(6):479–488.
31. Fagard RH. Dipping pattern of nocturnal blood pressure in
patients with hypertension. Expert Rev Cardiovasc Ther. 2009;
7(6):599–605.
32. Schwartz GJ, Muñoz A, Schneider MF, et al. New equations to
estimate GFR in children with CKD. J Am Soc Nephrol. 2009;
20(3):629–637.
33. Rosset S, Tzur S, Behar DM, et al. The population genetics of
chronic kidney disease: insights from theMYH9-APOL1 locus.
Nat Rev Nephrol. 2011;7(6):313–326.
34. Kwiatkowski DP. Howmalaria has affected the human
genome and what human genetics can teach us about malaria.
Am J HumGenet. 2005;77(2):171–192.
35. Tsaras G, Owusu-Ansah A, Boateng FO, et al. Complications
associated with sickle cell trait: a brief narrative review. Am J
Med. 2009;122(6):507–512.
36. Verdecchia P, Angeli F, Reboldi G. Does malaria cause
hypertension?Circ Res. 2016;119(1):7–9.
37. Sankoh O, Byass P. The INDEPTHNetwork: ﬁlling vital gaps
in global epidemiology. Int J Epidemiol. 2012;41(3):579–588.
38. Cruickshank JK, Mzayek F, Liu L, et al. Origins of the “black/
white” difference in blood pressure: roles of birth weight,
postnatal growth, early blood pressure, and adolescent body
size: the Bogalusa Heart Study.Circulation. 2005;111(15):
1932–1937.
39. Harding S, WhitrowM, Lenguerrand E, et al. Emergence of
ethnic differences in blood pressure in adolescence. The
Determinants of Adolescent Social Well-Being and Health
Study.Hypertension. 2010;55(4):1063–1069.
40. Chen X,Wang Y. Tracking of blood pressure from childhood
to adulthood: a systematic review and meta-regression
analysis. Circulation. 2008;117(25):3171–3180.
41. Stoner L, Lambrick DM,Westrupp N, et al. Validation of
oscillometric pulse wave analysis measurements in children.
Am J Hypertens. 2014;27(6):865–872.
Am J Epidemiol. 2018;187(2):199–205
Ambulatory Blood Pressure in Adolescents with Sickle Cell Trait 205
Downloaded from https://academic.oup.com/aje/article-abstract/187/2/199/3867261
by King's College London user
on 05 March 2018
